ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,467Medicare Part D Prescriptions Filled, Including Refills
$2M Total Retail Price of All Prescriptions
698 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
FUROSEMIDE 1,027 671
LEVOTHYROXINE SODIUM 1,014 697
METFORMIN HCL 982 648
LISINOPRIL 940 607
POTASSIUM CHLORIDE 926 642
AMLODIPINE BESYLATE 622 449
RANITIDINE HCL 556 365
GABAPENTIN 554 339
WARFARIN SODIUM 539 388
ATORVASTATIN CALCIUM 534 323
METOPROLOL TARTRATE 521 347
HYDROCODONE-ACETAMINOPHEN 512 357 S3
OMEPRAZOLE 493 301
CLOPIDOGREL 373 276
HYDROCHLOROTHIAZIDE 366 261
SIMVASTATIN 356 218
LOVASTATIN 355 221
NEXIUM 330 126
CARVEDILOL 310 228
JANUVIA 303 203
DONEPEZIL HCL 297 292
CRESTOR 294 201
PLAVIX 290 222
PROAIR HFA 284 123
ZETIA 281 164
CITALOPRAM HBR 269 202
ESCITALOPRAM OXALATE 255 166
NAMENDA 254 245
CYMBALTA 247 135
LANTUS 240 153
DIGOXIN 237 184
TRAMADOL HCL 235 157
ISOSORBIDE MONONITRATE ER 233 156
ADVAIR DISKUS 224 125
ZOLPIDEM TARTRATE 218 94
ATENOLOL 210 155
LISINOPRIL-HYDROCHLOROTHIAZIDE 210 108
ENALAPRIL MALEATE 202 158
LOVAZA 202 102
FLUTICASONE PROPIONATE 195 113
FLUOXETINE HCL 186 144
PRAVASTATIN SODIUM 181 122
TRICOR 178 95
SINGULAIR 176 83
LIPITOR 176 96
AMITRIPTYLINE HCL 175 78 R
PAROXETINE HCL 169 116
AZITHROMYCIN 169 94
LOSARTAN POTASSIUM 164 121
QUETIAPINE FUMARATE 164 121
SINGLE USE SWAB 162 59
PANTOPRAZOLE SODIUM 160 130
DIOVAN 153 119
METOCLOPRAMIDE HCL 152 112
SERTRALINE HCL 151 71
ROPINIROLE HCL 149 88
TAMSULOSIN HCL 149 95
CYCLOBENZAPRINE HCL 148 77 R
METOPROLOL SUCCINATE 144 108
LYRICA 143 71
ALLOPURINOL 143 118
FENOFIBRATE 140 87
PROPRANOLOL HCL 139 99
SPIRIVA 133 76
RISPERIDONE 126 90
DIVALPROEX SODIUM 122 73
DEXILANT 117 81
PEN NEEDLE 116 38
KETOPROFEN 115 67
LANTUS SOLOSTAR 111 64
LEXAPRO 110 60
CLONIDINE HCL 107 56
BUSPIRONE HCL 106 90
CARBIDOPA-LEVODOPA 106 94
GLIPIZIDE 105 83
VENTOLIN HFA 104 46
TRIAMTERENE-HCTZ 103 81
SYNTHROID 102 97
GLIPIZIDE ER 97 66
MONTELUKAST SODIUM 96 36
DILTIAZEM 24HR CD 96 69
INSULIN SYRINGE 94 37
BYSTOLIC 92 61
MECLIZINE HCL 90 78
LOSARTAN-HYDROCHLOROTHIAZIDE 90 75
DIOVAN HCT 88 40
CIPROFLOXACIN HCL 88 56
MIRTAZAPINE 86 58
PHENYTOIN SODIUM EXTENDED 85 55
LEVOFLOXACIN 85 57
NIASPAN 85 36
TRAMADOL HCL-ACETAMINOPHEN 82 59
DETROL LA 82 55
ESTRADIOL 82 50 R
TRIAMCINOLONE ACETONIDE 78 62
MEGESTROL ACETATE 78 74 R
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 49
GLIMEPIRIDE 75 63
ALENDRONATE SODIUM 75 75
PROMETHAZINE HCL 75 54 R
HYDROXYZINE HCL 74 40 R
LEVEMIR 72 55
SPIRONOLACTONE 71 32
NAPROXEN 70 26
PREDNISONE 70 58
LEVETIRACETAM 69 25
METFORMIN HCL ER 65 32
TRAZODONE HCL 65 32
BENICAR 64 43
ORPHENADRINE CITRATE 63 18 R
FENTANYL 63 53 S2
GEMFIBROZIL 63 44
GLYBURIDE 63 54 R
TRILIPIX 62 45
AMLODIPINE BESYLATE-BENAZEPRIL 61 54
VESICARE 61 49
TOPIRAMATE 61 0
CILOSTAZOL 61 55
FAMOTIDINE 61 41
COMBIVENT 61 14
CEPHALEXIN 60 30
BYETTA 60 21
LIDODERM 59 52
CELEBREX 58 19
SEROQUEL 58 53
GLYBURIDE-METFORMIN HCL 58 25 R
MELOXICAM 58 24
FINASTERIDE 58 27
LUNESTA 57 28
IBUPROFEN 57 31
OXYBUTYNIN CHLORIDE 56 45
VIIBRYD 56 13
VERAPAMIL ER 56 55
NASONEX 56 21
HYDROCORTISONE 56 36
LEVEMIR FLEXPEN 54 0
KLOR-CON M20 54 41
SYMBICORT 53 29
METHOCARBAMOL 53 27 R
ACETAMINOPHEN-CODEINE 52 39 S3
TERAZOSIN HCL 51 46
AMOX TR-POTASSIUM CLAVULANATE 50 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.